Global Effervescent Tablet Market Size, and Share, Growth Report 2030

The value of the global effervescent tablet market was approximately USD 5.3 billion in 2022, and analysts forecast that it will increase to approximately USD 8.7 billion by 2030, expanding at a compound annual growth rate (CAGR) of approximately 6.5% between 2023 and 2030.

Effervescent Tablet Market: Overview

An effervescent tablet is a pharmacological dosage form that is meant to dissolve fast in water, thereby releasing carbon dioxide gas and producing a pleasant bubbly, or effervescent, reaction. Effervescent tablets are available from a number of different manufacturers. Tablets like this are frequently used because they provide a structure that is simple, user-friendly, and convenient for administering drugs, vitamins, minerals, and other active components. Tablets often have a combination of active components, such as medications or nutrients, as well as a variety of excipients and a source of carbon dioxide. In addition, tablets typically contain a source of carbon dioxide. In most cases, the tablet is compressed by utilizing a mixture of citric acid and sodium bicarbonate. These two ingredients undergo a chemical reaction when dissolved in water, which results in the production of carbon dioxide bubbles. This effervescence serves to disseminate the contents of the tablet throughout the water, which makes it easier to ingest and also makes it easier for the contents to be absorbed. When compared to standard tablets or capsules, effervescent tablets have the potential to deliver a quicker start of action, which is one of the reasons why they are becoming increasingly popular. Because of the effervescence, the surface area of the tablet is increased, and the tablet dissolves more easily, which enables the body to absorb the active components in a shorter amount of time.

In addition, the bubbly quality of effervescent tablets can make them more appealing for individuals who have trouble swallowing regular tablets. The administration of a wide variety of pharmaceuticals, such as pain relievers, antacids, cold and flu cures, and nutritional supplements, is frequently accomplished through the use of effervescent tablet form. They are also commonly used in dietary supplements, such as vitamin C or multivitamins. This is due to the fact that they have a nice flavor and are simple to use, which both contribute to improved absorption and compliance. The growing elderly population, rising demand for dietary supplements, rising levels of innovation and product development, and rising rates of respiratory disease are just some of the factors that are driving growth in the global effervescent tablet market.

Effervescent Tablet Market: Growth Drivers

The expansion of the market is being driven by the rising prevalence of chronic diseases.

As the prevalence of chronic conditions continues to rise, it is projected that the market for effervescent tablet products would grow in the coming years. Chronic disorders typically last for three months or more and can deteriorate with time. Chronic diseases also tend to affect more people. The most prevalent forms of chronic illness are cancer, cardiovascular disease, stroke, diabetes, and rheumatoid arthritis. Effervescent pills are used in the treatment of chronic ailments such as diabetes, cancer, and heart disease. These pills are effective antioxidants that raise blood antioxidant levels and lessen the chance of developing chronic diseases.

Effervescent Tablet Market: Segmentation

The market for effervescent tablets is broken down into many submarkets depending on factors such as product, manufacturing technique, indication, application, end user, and geographic location.

The pharmaceutical and supplement sectors of the worldwide market are separated from one another on the basis of the product. The market for supplements is anticipated to experience the highest rate of growth throughout the course of the projection period. Effervescent pills are made to dissolve entirely and rapidly in water once they are exposed to the liquid. Because of this improved solubility, the active components in the product have a higher bioavailability compared to conventional tablets or capsules. The effervescence assists in dispersing the supplement throughout the liquid, which helps to ensure that it is distributed evenly and improves the body's ability to absorb it.

Effervescent Tablet Market: Regional Analysis

North America is expected to dominate the market during the forecast period

North America is expected to dominate the effervescent tablet market during the forecast period. The regional growth is ascribed to various factors such as the growing prevalence of chronic disorders and the presence of major market players. For instance, as per CDC data, in the United States, 1,603,844 new instances of cancer were reported in 2020, and 602,347 cancer-related deaths were recorded. 403 new instances of cancer and 144 cancer-related deaths were recorded for every 100,000 persons. Furthermore, the increasing geriatric population and the growing innovative product launches in the region propel the market revenue.

Effervescent Tablet Market: Competitive Analysis

The global effervescent tablet market is dominated by players like:

Bayer AG
Bristol-Myers Squibb Company
Novartis AG
Pfizer Inc.
Perrigo Company plc
Reckitt Benckiser Group PLC
GSK plc
CHIESI SAS
Hermes Pharma
S. G. Biopharm Pvt. Ltd
Bliss GVS Pharma Limited
Alpex
SCITECH
Vovantis Laboratories
Swisse Wellness PTY LTD
Herbalife International of America Inc.
Nuun
Natur Produkt Zdrovit Sp Z O O
Vitabiotics Ltd
Amerilab Technologies Inc.
HERMES ARZNEIMITTEL
Others.

The global effervescent tablet market is segmented as follows:

By Product

Medication
Supplements
By Methods

Dry Methods
Wet Granulation
By Indication

Pain Management
Diuretics
Gastric Disorders
Respiratory Diseases
Others
By Application

Dental Products
Dietary Supplements
Pharmaceutical
Others
By End User

Hospitals
Specialty Clinics
Homecare
Others
By Region
North America
The U.S.
Canada
Europe
France
The UK
Spain
Germany
Italy
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Southeast Asia
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East Africa
GCC
South Africa
Rest of Middle East Africa